s6y
Company name or ticker
Search
Atara Biotherapeutics, Inc.
3
Sarney Kevin G: Initial statement of beneficial ownership of securities
Filed
Monday, July 6, 2026
Period
Jun 26, 2026
Accession number
0000905148-26-003168
Documents
FORM 3
3
On sec.gov
Filing index
All files
Complete submission text
SGML header